Hormonal Agents · Progesterone and Progestins
Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate
Nilsen J et al., 2002
118 works
Perimenopause and Menopause
The hormonal transition, its symptoms, and restorative and hormonal options for the years around it.
In Perimenopause and Menopause
118 works
Ovulation Physiology · Anovulation
The ageing female reproductive axis II: ovulatory changes with perimenopause
Prior JC, 2002
Hormones and Bone · Estrogen and Bone
Perimenopausal bone loss: more than estrogen depletion
Prior JC et al., 2001
Hormonal Agents · Estrogen Preparations
[Hormone replacement therapy of menopause, heart and blood vessels]
Kuttenn F et al., 2001
Hormonal Agents · Progesterone and Progestins
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women
Rosano GM et al., 2000
Hormonal Agents · Estrogen Preparations
Cardiovascular pharmacology of hormone replacement therapy
Rosano GM et al., 1999
Hormonal Agents · Progesterone and Progestins
Oral micronized progesterone
de Lignières B, 1999
Hormonal Agents · Estrogen Preparations
Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow
Cacciatore B et al., 1998
Hormonal Agents · Estrogen Preparations
Ambulatory--not office--blood pressures decline during hormone replacement therapy in healthy postmenopausal women
van Ittersum FJ et al., 1998
Hormonal Agents · Estrogen Preparations
Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension
Mercuro G et al., 1998
Hormonal Agents · Estrogen Preparations
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
Hulley S et al., 1998
Hormones and Bone · Estrogen and Bone
Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women
Devogelaer JP et al., 1998
Hormonal Agents · Estrogen Preparations
Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism
Bhavnani BR, 1998
Hormones and Bone · Estrogen and Bone
Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate
Prior JC et al., 1997
Hormonal Agents · Estrogen Preparations
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy
Karjalainen A et al., 1997
Hormonal Agents · Estrogen Preparations
Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial
Snabes MC et al., 1997
Hormonal Agents · Progesterone and Progestins
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
Miyagawa K et al., 1997
Hormonal Agents · Estrogen Preparations
Treatment of skin aging with topical estrogens
Schmidt JB et al., 1996
Hormones and Bone · Estrogen and Bone
Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study
Minaguchi H et al., 1996
Hormonal Agents · Estrogen Preparations
Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. A randomized, double-blind, placebo-controlled, crossover study
Haines C et al., 1996
Hormones and Bone · Estrogen and Bone
Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages
Evans SF et al., 1996
Hormonal Agents · Estrogen Preparations
Estrogen acutely increases peripheral blood flow in postmenopausal women
Volterrani M et al., 1995
Hormonal Agents · Estrogen Preparations
Effects of Estrogen or Estrogen/Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
Miller VT et al., 1995
Hormonal Agents · Progesterone and Progestins
Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
Williams JK et al., 1994
Hormonal Agents · Progesterone and Progestins
No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial
Prior JC et al., 1994
Hormonal Agents · Estrogen Preparations
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
Raz R et al., 1993
Osteoporosis · Diagnosis and Treatment
Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study
Tuppurainen M et al., 1993
Hormones and Bone · Estrogen and Bone
Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause
Reginster JY et al., 1993
Ovarian Hormones · Progesterone
The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone
Simon JA et al., 1993
Hormonal Agents · Estrogen Preparations
Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women
Kirkengen AL et al., 1992
Long Term Health · Metabolic Risk
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones
Dahlgren E et al., 1992
Hormones and Bone · Estrogen and Bone
Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women
Ettinger B et al., 1992
Hormonal Agents · Progesterone and Progestins
Absorption of micronized progesterone from a nonliquefying vaginal cream
Kimzey LM et al., 1991
Ovarian Hormones · Progesterone
Progesterone administration by nasal spray
Cicinelli E et al., 1991
Ovarian Hormones · Estrogen
Pharmacokinetics of oestrogens and progestogens
Kuhl H, 1990
Hormonal Agents · Estrogen Preparations
Pharmacokinetics of estrogen
Stumpf PG, 1990
Ovarian Hormones · Progesterone
Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review
Sitruk-Ware R et al., 1987
Ovarian Hormones · Progesterone
Absorption and metabolism of oral progesterone when administered twice daily
Padwick ML et al., 1986
Ovarian Hormones · Progesterone
Bioavailability of oral micronized progesterone
Maxson WS et al., 1985
Ovarian Hormones · Progesterone
Intravaginal administration of progesterone: enhanced absorption after estrogen treatment
Villanueva B et al., 1981
Hormonal Agents · Estrogen Preparations
Estriol in the management of the menopause
Tzingounis VA et al., 1978
Ovarian Hormones · Estrogen
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women
Yen SS et al., 1975
